The landscape for pharmaceutical manufacturing in the United States underwent a significant shift on September 29, 2026, as the scope…
Read More
DFE Pharma Expands Continuous Manufacturing Capabilities to Address Industry-Wide Adoption Challenges in Pharmaceutical Production
The global pharmaceutical manufacturing sector is undergoing a profound paradigm shift, moving steadily away from traditional batch processing toward continuous…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…
Read More
Pi Coding Agents: A Deep Dive into the Minimalist AI Assistant Challenging Industry Norms
In an era dominated by artificial intelligence tools that promise ever-increasing capabilities and seamless, feature-rich integrations, a new player has…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The United States Food and Drug Administration (FDA) embarked on a pivotal initiative in June 2025 with the announcement of…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The United States Food and Drug Administration (FDA) embarked on a bold new initiative in June 2025 with the announcement…
Read More
Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.
The recent inauguration of THE HIVE at Campus Grand Parc in Paris marks a significant inflection point for Europe’s oncology…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The U.S. Food and Drug Administration (FDA) launched its Commissioner’s National Priority Voucher (CNPV) pilot program in June 2025, an…
Read More
Biopharmaceutical Executives Express Record Optimism as Industry Navigates Disruption Through Strategic Dealmaking
Biopharmaceutical executives are demonstrating their highest level of confidence in the industry’s growth prospects in four years, a significant turnaround…
Read More
